Export this Data | Chart Risk Level by Product Clear Chart
Add More Filters: Risk_level, Active_ingredient, Use_site, Surface_type, Why_on_List_N,
Formulation_type (array) ✖
ID ▼ | EPA_reg_num | Risk_level | Active_ingredient | Product_name | Company | Use_site | Surface_type | Contact_time | Formulation_type | Follow_directions_for_this_virus | Date_on_List_N | Why_on_List_N |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1029 | 92378-2 | Increased Risk | Quaternary ammonium | Atmosphere | Atmosphere Global LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-09-28 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1056 | 1839-166 | Increased Risk | Quaternary ammonium | BTC 885 NDC-128 | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-10-15 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1067 | 1839-167 | Increased Risk | Quaternary ammonium | BTC 885 Neutral Disinfectant Cleaner-256 | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-10-08 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1068 | 1839-169 | Increased Risk | Quaternary ammonium | BTC 885 Neutral Disinfectant Cleaner-64 | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-10-08 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1069 | 1839-168 | Increased Risk | Quaternary ammonium | BTC 885 NDC-32 | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-10-08 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1070 | 1839-176 | Increased Risk | Quaternary ammonium | Liquid-pak Neutral Disinfectant Cleaner | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-10-08 | Tested against SARS-CoV-2 (COVID-19) |
1099 | 6836-136 | Increased Risk | Quaternary ammonium | Lonza Formulation S-18F | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1100 | 6836-140 | Increased Risk | Quaternary ammonium | Lonza Formulation S-21F | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1102 | 6836-77 | Increased Risk | Quaternary ammonium | Lonza Formulation S-18 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1103 | 6836-381 | Increased Risk | Quaternary ammonium | Lonzagard R-82G | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1104 | 6836-139 | Increased Risk | Quaternary ammonium | Lonza Formulation R-82F | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1105 | 6836-346 | Increased Risk | Quaternary ammonium | Lonzagard RCS-256 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-27 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1106 | 6836-347 | Increased Risk | Quaternary ammonium | Lonzagard RCS-128 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-27 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1107 | 6836-348 | Increased Risk | Quaternary ammonium | Lonzagard RCS-128 PLUS | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-27 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1108 | 6836-349 | Increased Risk | Quaternary ammonium | Lonzagard RCS-256 Plus | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-27 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1109 | 6836-75 | Increased Risk | Quaternary ammonium | Lonza Formulation S-21 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1110 | 6836-78 | Increased Risk | Quaternary ammonium | Lonza Formulation R-82 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1147 | 45745-11 | Safer | Hydrogen peroxide | HP2O2 | Midlab | Healthcare; Institutional | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable; Electrostatic spray | SARS-CoV-2 | 2021-07-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1170 | 39967-138 | Increased Risk | Potassium peroxymonosulfate; Sodium chloride | Rely+On Virkon | Lanxess Corporation | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-09-28 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1185 | 1839-100 | Increased Risk | Quaternary ammonium | Veterinarian Type Disinfectant | Stepan Company | Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-03-26 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1197 | 89833-3 | Increased Risk | Quaternary ammonium | D7 Part 1 | Decon7 Systems LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-20 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1198 | 91399-2 | Increased Risk | Sodium chlorite | Biotab7 | Advanced Biocide Technologies Inc | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact No Rinse (FCNR) | 1.0 minutes | Dilutable | Feline calicivirus; Norovirus | 2020-03-26 | Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1205 | 1839-80 | Increased Risk | Quaternary ammonium | NP 12.5 Detergent/Disinfectant | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-03-26 | Tested against SARS-CoV-2 (COVID-19) |
1206 | 1839-97 | Increased Risk | Quaternary ammonium | NP 12.5 (D&F) Detergent/Disinfectant | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-03-26 | Tested against SARS-CoV-2 (COVID-19) |
1270 | 71355-1 | Increased Risk | Quaternary ammonium; Glutaraldehyde | Virocid | CID Lines NV | Institutional | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-10-26 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1345 | 1839-96 | Increased Risk | Quaternary ammonium | NP 9.0 (D&F) Detergent/disinfectant | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-04-23 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1351 | 89833-4 | Safer | Hydrogen peroxide | D7 Part 2 | Decon7 Systems LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-20 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1355 | 3573-77 | Increased Risk | Sodium hypochlorite | CSP-3002-3 | The Proctor & Gamble Company | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | Norovirus; Poliovirus | 2020-04-16 | Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1380 | 10324-230 | Increased Risk | Hydrogen peroxide; Peroxyacetic acid (Peracetic acid) | Maguard 1522 | Mason Chemical Company | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | Human coronavirus | 2020-03-13 | Kills a human coronavirus similar SARS-CoV-2 (COVID-19) |
1400 | 1839-81 | Increased Risk | Quaternary ammonium | NP 9.0 Detergent/disinfectant | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-03-13 | Tested against SARS-CoV-2 (COVID-19) |
1409 | 54289-4 | Increased Risk | Peroxyacetic acid (Peracetic acid) | Peraclean 15 (Peroxyacetic Acid Solution) | Evonik Corporation | Healthcare; Institutional | Hard Nonporous (HN) | 1.0 minutes | Dilutable | Human coronavirus | 2020-03-13 | Kills a human coronavirus similar SARS-CoV-2 (COVID-19) |
1440 | 6836-362 | Increased Risk | Quaternary ammonium | Nugen MB5A-128 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-03-02 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1441 | 6836-363 | Increased Risk | Quaternary ammonium | Nugen MB5A-64 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-03-02 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1442 | 6836-366 | Increased Risk | Quaternary ammonium | Nugen MB5N-64 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-27 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1459 | 47371-129 | Increased Risk | Quaternary ammonium | Formulation HWS- 256 | H&S Chemicals Division of Arxada LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-05-25 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1460 | 47371-130 | Increased Risk | Quaternary ammonium | Formulation HWS-128 | H&S Chemicals Division of Arxada LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-05-25 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1461 | 47371-131 | Increased Risk | Quaternary ammonium | HWS-64 | H&S Chemicals Division of Arxada LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-05-25 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1462 | 47371-192 | Increased Risk | Quaternary ammonium | Formulation HWS-32 | H&S Chemicals Division of Arxada LLC | Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-05-25 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1483 | 6836-361 | Increased Risk | Quaternary ammonium | Nugen MB5A-256 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-03-02 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1484 | 6836-364 | Increased Risk | Quaternary ammonium | Nugen MB5N-256 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-27 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1485 | 6836-365 | Increased Risk | Quaternary ammonium | Nugen MB5N-128 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-27 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1488 | 70627-58 | Safer | Hydrogen peroxide | Oxy-Team™ Disinfectant Cleaner | Diversey Inc | Healthcare; Institutional | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-03-03 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1490 | 70627-72 | Increased Risk | Sodium hypochlorite | Avert Sporicidal Disinfectant Cleaner | Diversey Inc | Healthcare; Institutional | Hard Nonporous (HN) | 1.0 minutes | Dilutable | Canine parvovirus; Norovirus; Hepatitis A virus; Poliovirus Type 1 | 2020-03-03 | Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1493 | 71847-6 | Increased Risk | Sodium dichloroisocyanurate | Klorsept | Medentech LTD | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable; Electrostatic Spray | SARS-CoV-2 | 2021-01-28 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1530 | 88494-1 | Increased Risk | Quaternary ammonium; Ethanol (Ethyl alcohol) | Wedge Disinfectant | North American Infection Control LTD | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | Human coronavirus | 2020-03-13 | Kills a human coronavirus similar SARS-CoV-2 (COVID-19) |
1620 | 98099-1 | Increased Risk | Sodium chlorite | PX10 | PX10 LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | Feline calicivirus | 2021-01-07 | Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1665 | 89492-2 | Increased Risk | Sodium chlorite | Dutrion Tablet | Dutrion North America Ltd | Healthcare; Institutional | Hard Nonporous (HN) | 1.0 minutes | Dilutable | Rotavirus | 2021-01-28 | Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1742 | 66243-2 | Increased Risk | Quaternary ammonium | Odo-Ban | Clean Control Corp | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | Human coronavirus | 2021-03-16 | Kills a human coronavirus similar SARS-CoV-2 (COVID-19) |
2122 | 85837-6 | Increased Risk | Hydrogen peroxide; Peroxyacetic acid (Peracetic acid) | Peraoxy Pro | Innovasource LLC | Healthcare; Institutional | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | Human coronavirus | 2021-07-13 | Kills a human coronavirus similar SARS-CoV-2 (COVID-19) |
2229 | 6836-138 | Increased Risk | Quaternary ammonium | Lonza Formulation S-38-F | Arxada, LLC | Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-11-23 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
2230 | 6836-73 | Increased Risk | Quaternary ammonium | Lonza Formulation S-38 | Arxada, LLC | Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-11-23 | Tested against SARS-CoV-2 (COVID-19) |
2408 | 70627-84 | Increased Risk | Quaternary ammonium | Virex Plus | Diversey, Inc | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2022-08-31 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
2409 | 10324-194 | Increased Risk | Quaternary ammonium | Maquat 2420-10 | Mason Chemical Company | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2022-08-31 | Tested against SARS-CoV-2 (COVID-19) |
2412 | 63838-36 | Increased Risk | Quaternary ammonium | EP-Q7.5 | Enviro Tech Chemical Services, Inc. | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2022-08-31 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
2622 | 5813-135 | Safer | Citric acid | Pyn | The Clorox Company | Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2023-08-02 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
Safer Disinfectants is a project of the Maryland Pesticide Education Network
© 2021. All rights reserved.